NIH partners 11 drugmakers to accelerate cancer therapy research


REUTERS: The National Institutes of Health said on Thursday it had partnered 11 biopharma companies to help advance a new class of drugs that uses the body's immune system to fight cancer. The five-year public-private research collaboration, called Partnership for Accelerating Cancer Therapies, includes drugmakers AbbVie, Roche Holding AG and Bristol-Myers Squibb.



from Biotech News